0,962  0,004  Apoptosis agonist
0,955  0,002  Chemopreventive
0,931  0,001  Caspase 3 stimulant
0,895  0,003  Nitric oxide antagonist
0,872  0,008  Transcription factor NF kappa B inhibitor
0,835  0,004  Bone diseases treatment
0,836  0,011  Antiinflammatory
0,831  0,008  CYP3A4 substrate
0,812  0,004  Antiosteoporotic
0,746  0,005  Lipoprotein disorders treatment
0,712  0,005  Antipsoriatic
0,711  0,007  Cholesterol antagonist
0,712  0,019  Antineoplastic (breast cancer)
0,698  0,007  Atherosclerosis treatment
0,677  0,012  Antihypercholesterolemic
0,661  0,007  Hepatic disorders treatment
0,634  0,015  Prostate cancer treatment
0,622  0,005  Antineoplastic (liver cancer)
0,622  0,014  Antineoplastic (ovarian cancer)
0,618  0,010  Antiprotozoal (Plasmodium)
0,614  0,007  Antifungal
0,592  0,004  Antiparkinsonian, rigidity relieving
0,603  0,018  Antiprotozoal
0,594  0,011  NOS3 expression inhibitor
0,603  0,024  Antileukemic
0,564  0,008  Hypolipemic
0,581  0,033  Antineoplastic (lung cancer)
0,566  0,018  Immunosuppressant
0,519  0,017  Antineoplastic (brain cancer)
0,492  0,002  Liver X receptor alpha agonist
0,471  0,005  Sodium/bile acid cotransporter inhibitor
0,474  0,023  Antineoplastic (glioma)
0,458  0,007  Prostate disorders treatment
0,458  0,008  Contraceptive
0,445  0,009  Interferon gamma antagonist
0,445  0,021  UGT2B4 substrate
0,454  0,030  Immunomodulator
0,425  0,005  DNA polymerase I inhibitor
0,430  0,018  Antineoplastic (renal cancer)
0,433  0,025  Proliferative diseases treatment
0,411  0,010  Antiacne
0,411  0,010  UGT2B7 substrate
0,469  0,073  Caspase 9 stimulant
0,405  0,012  Prostatic (benign) hyperplasia treatment
0,416  0,032  Antioxidant
0,368  0,006  Antineoplastic antibiotic
0,390  0,032  Antiprotozoal (Leishmania)
0,369  0,015  Diuretic
0,398  0,044  Teratogen
0,422  0,079  Cyclophilin D inhibitor
0,422  0,079  Antidiabetic
0,350  0,007  Cholesterol synthesis inhibitor
0,368  0,033  Tumour necrosis factor alpha release inhibitor
0,350  0,019  Hepatoprotectant
0,352  0,022  UGT1A4 substrate
0,323  0,007  Neurotrophic factor
0,319  0,007  Interleukin 4 antagonist
0,328  0,016  Lipocortins synthesis antagonist
0,313  0,005  Farnesoid X receptor antagonist
0,356  0,053  Apoptosis antagonist
0,347  0,044  Cytotoxic
0,334  0,037  Angiogenesis stimulant
0,304  0,010  Butyrylcholinesterase inhibitor
0,295  0,005  Antifungal (Cryptococcus)
0,304  0,021  Antipruritic, non-allergic
0,332  0,053  Embryotoxic
0,368  0,092  Antibacterial
0,308  0,033  Abortion inducer
0,324  0,051  Antineoplastic (cervical cancer)
0,332  0,060  Antineoplastic (melanoma)
0,311  0,047  Antineoplastic (lymphoma)
0,270  0,008  Androgen antagonist
0,283  0,023  Hair growth stimulant
0,320  0,061  Interleukin 2 agonist
0,322  0,074  Antihypertensive
0,251  0,004  Liver X receptor agonist
0,281  0,037  UGT1A1 substrate
0,282  0,039  UDP-glucuronosyltransferase substrate
0,308  0,066  Antineoplastic (pancreatic cancer)
0,246  0,005  Inducible nitric-oxide synthase inhibitor
0,262  0,022  Antiviral (Influenza A)
0,335  0,099  Antipruritic, allergic
0,276  0,043  Antineoplastic enhancer
0,240  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,272  0,050  Carcinogenic
0,243  0,022  UGT2B9 substrate
0,221  0,004  Hyperparathyroidism treatment
0,272  0,056  Antineoplastic (glioblastoma multiforme)
0,213  0,004  Hypercalcemia treatment
0,254  0,045  Antiviral (Influenza)
0,291  0,088  AR expression inhibitor
0,236  0,035  Protein-tyrosine phosphatase inhibitor
0,270  0,076  Renal disease treatment
0,259  0,065  Sensitization
0,290  0,096  ICAM1 expression inhibitor
0,197  0,012  Pregnane X receptor agonist
0,274  0,089  CTGF expression inhibitor
0,240  0,066  UGT1A6 substrate
0,201  0,032  Arachidonic acid antagonist
0,239  0,078  NOS2 expression inhibitor
0,294  0,134  TNF expression inhibitor
0,243  0,090  Chemoprotective
0,191  0,046  Interleukin 6 antagonist
0,153  0,012  CDC25A inhibitor
0,193  0,053  Liver fibrosis treatment
0,178  0,043  Skin whitener
0,144  0,012  Postmenopausal disorders treatment
0,157  0,030  Alcohol dehydrogenase substrate
0,206  0,080  Antihypertriglyceridemic
0,127  0,003  Vitamin D receptor antagonist
0,152  0,029  HDL-cholesterol increasing
0,206  0,083  Antiparasitic
0,141  0,019  UGT2B11 substrate
0,131  0,011  Na+ K+ transporting ATPase inhibitor
0,141  0,023  Anabolic
0,173  0,063  UGT2B10 substrate
0,226  0,116  Antineoplastic (colorectal cancer)
0,216  0,106  Interleukin agonist
0,136  0,027  Interleukin 2 antagonist
0,112  0,003  Parathyroid hormone antagonist
0,140  0,031  Antiinfertility, female
0,217  0,112  Antineoplastic (colon cancer)
0,157  0,054  Bone formation stimulant
0,115  0,012  Anticholelithogenic
0,108  0,007  Mineralocorticoid receptor antagonist
0,136  0,036  UGT2B1 substrate
0,119  0,021  Antiprotozoal activity enhancer
0,137  0,045  Contraceptive female
0,107  0,017  Glycine receptor agonist
0,142  0,054  Antihemorrhagic
0,132  0,049  Microtubule formation inhibitor
0,156  0,073  Urolithiasis treatment
0,093  0,011  5-Alpha-reductase inhibitor
0,139  0,058  Antihyperlipoproteinemic
0,110  0,030  Antibiotic
0,125  0,045  Antischistosomal
0,081  0,008  RNA-directed RNA polymerase stimulant
0,176  0,103  Neurotrophic factor enhancer
0,113  0,043  Nitric-oxide synthase inhibitor
0,109  0,039  SULT1E1 substrate
0,151  0,082  UGT1A3 substrate
0,073  0,004  HMG CoA reductase inhibitor
0,163  0,096  Antihelmintic
0,077  0,015  Lipocortins synthesis agonist
0,082  0,023  Androgen agonist
0,161  0,102  Anesthetic general
0,093  0,033  T cell inhibitor
0,099  0,051  ABCA1 expression enhancer
0,057  0,011  Farnesoid X receptor agonist
0,069  0,025  Acetyl-CoA transferase inhibitor
0,098  0,054  Bile acid receptor antagonist
0,083  0,041  SULT1A2 substrate
0,052  0,010  Glucose-6-phosphate dehydrogenase inhibitor
0,047  0,005  CYP24 inhibitor
0,042  0,004  Hedgehog signaling activator
0,119  0,082  Anesthetic
0,052  0,015  Acetyl-CoA transferase 1 inhibitor
0,122  0,086  Antifungal enhancer
0,092  0,057  Actinic keratosis treatment
0,055  0,021  Microtubule stabilization
0,131  0,097  Antiviral (Herpes)
0,092  0,059  Paget's disease treatment
0,033  0,003  Vitamin D receptor agonist
0,144  0,115  Diabetic nephropathy treatment
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,106  0,088  Growth stimulant
0,019  0,001  Vitamin D-like
0,074  0,057  Antitreponemal
0,038  0,022  Estrogen receptor alpha agonist
0,164  0,148  Vascular (periferal) disease treatment
0,038  0,023  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,049  0,036  Estrogen agonist
0,143  0,130  Toxic, respiratory center
0,113  0,100  Liver cirrhosis treatment
0,113  0,104  UGT2B15 substrate
0,019  0,011  Progesterone agonist
0,013  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,021  0,015  Corticosteroid-like
0,087  0,081  Sulfotransferase substrate
0,039  0,034  Cholesterol absorption inhibitor
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,091  0,088  Choleretic
0,078  0,076  Vanilloid agonist
0,122  0,120  Adenylate cyclase stimulant
0,055  0,055  Transcription factor AP-1 inhibitor

